Free Newsletter
Roche still confident on Ventana buyout
Does he know something we don't? Roche CEO Franz Humer says he's "very confident" that the company's $3 billion takeover bid for Ventana will be accepted.
Humer also told the Financial Times today that hedge funds have bought out Ventana's leading shareholders. And he has "no intention" of increasing the value of Roche's tender offer, despite the fact that the $75 buyout price is less than Ventana's current stock price.
- read the Financial Times article
Related Articles:
Roche asks, Ventana says no...again. Report
Roche wins round in battle for Ventana. Report
Roche note opens door to a higher Ventana bid. Report
Ventana spurns Roche's $3B hostile takeover bid. Report
Ventana shares soar on hostile $3B bid. Report
Read more on: Roche
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: